Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.455
+0.415 (13.65%)
Jun 29, 2026, 3:23 PM EDT - Market open
Perspective Therapeutics Employees
As of December 31, 2025, Perspective Therapeutics had 166 total employees, including 163 full-time and 3 part-time employees. The number of employees increased by 26 or 18.57% compared to the previous year.
Employees
166
Change (1Y)
26
Growth (1Y)
18.57%
Revenue / Employee
$3,723
Profits / Employee
-$669,476
Market Cap
394.03M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,450 |
| Orthofix Medical | 1,605 |
| Viemed Healthcare | 1,387 |
| Treace Medical Concepts | 450 |
| Standard BioTools | 389 |
| Sight Sciences | 186 |
| Electromed | 180 |
| 908 Devices | 172 |
CATX News
- 2 days ago - Perspective Therapeutics management to meet virtually with BTIG - TheFly
- 26 days ago - Perspective announces first patient dosed with (212Pb)VMT-alpha-NET - TheFly
- 26 days ago - Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-α-NET in the Meningioma Cohort of a Phase 1/2a Study - GlobeNewsWire
- 5 weeks ago - Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma - GlobeNewsWire
- 5 weeks ago - Perspective Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Perspective Therapeutics doses first patients in two Phase 1/2a studies - TheFly
- 6 weeks ago - Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies - GlobeNewsWire
- 6 weeks ago - Perspective Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts